A historic stem cell transplant at UT Southwestern Medical Center saved Chuck Dandridge's life. A decade later, he is advocating for more people to participate in bone marrow transplant clinical trials like he did.
The pediatric teams for AML therapy with KYMRIAH at UT Southwestern and Children’s Health explore how CAR T-cell technology can treat other cancers. Learn more.
An increasing number of adolescents and young adults are developing cancer, and they face unique challenges because the illness occurs during a crucial time of personal growth. It's vital that patients' care teams focus on their priorities for treatment and goals for survivorship.
Treatment options for acute myeloid leukemia (AML) in seniors have remained stagnant for 40 years. We are participating in Beat AML, a research study focused on swift phenotyping and tailored therapies, with the ultimate goal of improving outcomes in this disease that otherwise becomes increasingly difficult to treat as patients age.
As new CAR T-cell therapies are being approved to treat certain cancers, UT Southwestern explains how its team is working to further revolutionize treatment for more cancer patients.
